The Latest Cardiac and Vascular News
ATLANTA, July 30, 2019 /PRNewswire/ — Second Quarter and Recent Business Highlights: Total revenues were $71.1 million in the second quarter of 2019, reflecting year over year growth of 4% and a 7% increase on a non-GAAP constant currency basis, both compared to the second quarter of 2018 BioGlue® revenues increased 5%, and 7% on […]
ATLANTA, April 30, 2019 /PRNewswire/ — First Quarter and Recent Business Highlights: Total revenues were $67.5 million in the first quarter of 2019, reflecting year over year growth of 9% and an 11% increase on a non-GAAP constant currency basis, both compared to the first quarter of 2018 On-X® revenues increased 14%, and 15% on […]
ATLANTA, March 5, 2019 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 at The Boston Marriott Copley Place in Boston. A live webcast of the Company’s presentation is […]
ATLANTA, Feb. 13, 2019 /PRNewswire/ — Fourth Quarter and Recent Business Highlights: Total revenues were $67.8 million in the fourth quarter of 2018, reflecting year over year growth of 28% and an 8% increase on a non-GAAP constant currency basis compared to the fourth quarter of 2017 On-X® revenues increased 13% in the fourth quarter […]
ATLANTA, Oct. 31, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2018. Third Quarter and Recent Business Highlights: Total revenues increased 47 percent to $64.6 million in the third quarter of 2018 compared to the […]
ATLANTA, Oct. 15, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, in anticipation of discussions with its senior lenders regarding repricing its senior secured credit facility, today announced certain preliminary unaudited financial results for the third quarter of 2018. Preliminary and unaudited revenue […]
ATLANTA, Aug. 6, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the second quarter ended June 30, 2018. Second Quarter and Recent Business Highlights: Total revenues increased 43% to $68.5 million in the second quarter of 2018 compared to the second […]
ATLANTA, July 26, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 38th Annual Canaccord Genuity Growth Conference on Thursday, August 9, 2018 at the InterContinental Boston Hotel. A live webcast of the Company’s presentation is scheduled to begin at 11:30 […]
ATLANTA, July 18, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 second quarter financial results will be released on Monday, August 6, 2018 after the market closes. On Tuesday, August 7, 2018 the Company will hold a teleconference call and live webcast at 8:30 […]
ATLANTA, June 11, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announces the publication of our clinical study entitled “Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement” in a peer-reviewed medical journal, the Journal of the American College of Cardiology. The publication reports outcomes from […]
